Baidu
map

感染

订阅

MedSci主页 / 所有栏目 / 感染

Eur Respir J：艾滋病病毒感染者非传染性肺疾病负担增加

2018-09-23 xing.T MedSci原创

PLHIV非传染性肺疾病负担
关注

由此可见，在PLHIV中发生非感染性肺疾病，特别是COPD、肺气肿、肺纤维化、PAH和慢性呼吸道疾病，这表明对该人群中进行大规模筛查是正确的。

艾滋病病毒感染者（PLHIV）艾滋病发病率的总体降低以及肺疾病谱发生了变化。近日，呼吸疾病领域权威杂志Eur Respir J上发表了一篇研究文章，研究人员旨在更新法国住院的PLHIV肺疾病患病率的流行病学的最新情况。

研究人员分析了从法国全国医院医疗信息数据库中获取的2007年至2013年期间法国住院的PLHIV的肺疾病患病率，并评估了4年随访期间艾滋病与非传染性疾病之间的关系。

2007年至2013年期间，共有52091名PLHIV在法国住院治疗。在住院治疗肺疾病的PLHIV中，非传染性肺病在2007年至2013年期间从45.6％显著增加至54.7％，但是至少有一次感染性肺疾病的患者比例显著下降。2010年，研究人员将10067名普遍住院的PLHIV与8244 682名非PLHIV住院患者进行了比较。在30-49岁的患者中，即使在调整吸烟后，HIV感染也与慢性阻塞性肺病（COPD）、慢性呼吸衰竭、肺气肿、肺纤维化和肺动脉高压（PAH）有关。

由此可见，在PLHIV中发生非感染性肺疾病，特别是COPD、肺气肿、肺纤维化、PAH和慢性呼吸道疾病，这表明对该人群中进行大规模筛查是正确的。

原始出处：

Thomas Maitre,et al. Increasing burden of noninfectious lung disease in persons living with HIV: a 7-year study using the French nationwide hospital administrative database. Eur Respir J. 2018. http://erj.ersjournals.com/content/52/3/1800359

本文系梅斯医学（MedSci）原创编译整理，转载需授权！

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1911499, encodeId=25ac19114991e, content=<a href='/topic/show?id=77b3259009f' target=_blank style='color:#2F92EE;'>#传染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25900, encryptionId=77b3259009f, topicName=传染性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Tue Jul 30 23:47:00 CST 2019, time=2019-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1333600, encodeId=e21f1333600d8, content=<a href='/topic/show?id=1a1de07305e' target=_blank style='color:#2F92EE;'>#疾病负担#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70730, encryptionId=1a1de07305e, topicName=疾病负担)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/B389FA68ECBF51BE2FE14093CF61F6AE/100, createdBy=eb8e2500096, createdName=夏天与十三菇凉, createdTime=Tue Sep 25 01:47:00 CST 2018, time=2018-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548656, encodeId=d4ee15486560f, content=<a href='/topic/show?id=8aaf868262a' target=_blank style='color:#2F92EE;'>#艾滋病病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86826, encryptionId=8aaf868262a, topicName=艾滋病病毒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42f014104093, createdName=yige2008, createdTime=Tue Sep 25 01:47:00 CST 2018, time=2018-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346298, encodeId=a8fe346298cf, content=好文，值得点赞！认真学习，应用于实践！谢谢分享给广大同好！, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30251637888, createdName=lietome15, createdTime=Sun Sep 23 11:07:05 CST 2018, time=2018-09-23, status=1, ipAttribution=)]
    2019-07-30 xzw113

    #传染性#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1911499, encodeId=25ac19114991e, content=<a href='/topic/show?id=77b3259009f' target=_blank style='color:#2F92EE;'>#传染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25900, encryptionId=77b3259009f, topicName=传染性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Tue Jul 30 23:47:00 CST 2019, time=2019-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1333600, encodeId=e21f1333600d8, content=<a href='/topic/show?id=1a1de07305e' target=_blank style='color:#2F92EE;'>#疾病负担#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70730, encryptionId=1a1de07305e, topicName=疾病负担)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/B389FA68ECBF51BE2FE14093CF61F6AE/100, createdBy=eb8e2500096, createdName=夏天与十三菇凉, createdTime=Tue Sep 25 01:47:00 CST 2018, time=2018-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548656, encodeId=d4ee15486560f, content=<a href='/topic/show?id=8aaf868262a' target=_blank style='color:#2F92EE;'>#艾滋病病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86826, encryptionId=8aaf868262a, topicName=艾滋病病毒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42f014104093, createdName=yige2008, createdTime=Tue Sep 25 01:47:00 CST 2018, time=2018-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346298, encodeId=a8fe346298cf, content=好文，值得点赞！认真学习，应用于实践！谢谢分享给广大同好！, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30251637888, createdName=lietome15, createdTime=Sun Sep 23 11:07:05 CST 2018, time=2018-09-23, status=1, ipAttribution=)]
    2018-09-25 夏天与十三菇凉

    #疾病负担#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1911499, encodeId=25ac19114991e, content=<a href='/topic/show?id=77b3259009f' target=_blank style='color:#2F92EE;'>#传染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25900, encryptionId=77b3259009f, topicName=传染性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Tue Jul 30 23:47:00 CST 2019, time=2019-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1333600, encodeId=e21f1333600d8, content=<a href='/topic/show?id=1a1de07305e' target=_blank style='color:#2F92EE;'>#疾病负担#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70730, encryptionId=1a1de07305e, topicName=疾病负担)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/B389FA68ECBF51BE2FE14093CF61F6AE/100, createdBy=eb8e2500096, createdName=夏天与十三菇凉, createdTime=Tue Sep 25 01:47:00 CST 2018, time=2018-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548656, encodeId=d4ee15486560f, content=<a href='/topic/show?id=8aaf868262a' target=_blank style='color:#2F92EE;'>#艾滋病病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86826, encryptionId=8aaf868262a, topicName=艾滋病病毒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42f014104093, createdName=yige2008, createdTime=Tue Sep 25 01:47:00 CST 2018, time=2018-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346298, encodeId=a8fe346298cf, content=好文，值得点赞！认真学习，应用于实践！谢谢分享给广大同好！, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30251637888, createdName=lietome15, createdTime=Sun Sep 23 11:07:05 CST 2018, time=2018-09-23, status=1, ipAttribution=)]
    2018-09-25 yige2008

    #艾滋病病毒#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1911499, encodeId=25ac19114991e, content=<a href='/topic/show?id=77b3259009f' target=_blank style='color:#2F92EE;'>#传染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25900, encryptionId=77b3259009f, topicName=传染性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Tue Jul 30 23:47:00 CST 2019, time=2019-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1333600, encodeId=e21f1333600d8, content=<a href='/topic/show?id=1a1de07305e' target=_blank style='color:#2F92EE;'>#疾病负担#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70730, encryptionId=1a1de07305e, topicName=疾病负担)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/B389FA68ECBF51BE2FE14093CF61F6AE/100, createdBy=eb8e2500096, createdName=夏天与十三菇凉, createdTime=Tue Sep 25 01:47:00 CST 2018, time=2018-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548656, encodeId=d4ee15486560f, content=<a href='/topic/show?id=8aaf868262a' target=_blank style='color:#2F92EE;'>#艾滋病病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86826, encryptionId=8aaf868262a, topicName=艾滋病病毒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42f014104093, createdName=yige2008, createdTime=Tue Sep 25 01:47:00 CST 2018, time=2018-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=346298, encodeId=a8fe346298cf, content=好文，值得点赞！认真学习，应用于实践！谢谢分享给广大同好！, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30251637888, createdName=lietome15, createdTime=Sun Sep 23 11:07:05 CST 2018, time=2018-09-23, status=1, ipAttribution=)]
    2018-09-23 lietome15

    好文，值得点赞！认真学习，应用于实践！谢谢分享给广大同好！

    0

Baidu
map
Baidu
map
Baidu
map